Results 261 to 270 of about 163,785 (367)
The Role of Aging in Heart Failure With Preserved Ejection Fraction: Focus on Proteostatic Imbalance. [PDF]
Salzano A, Cittadini A.
europepmc +1 more source
Comparison of Beta-Blocker Effectiveness in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection Fraction [PDF]
Mostafa El-Refai+7 more
openalex +1 more source
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad+9 more
wiley +1 more source
Evolving role of myocardial fibrosis in heart failure with preserved ejection fraction. [PDF]
Malik MK+4 more
europepmc +1 more source
TRPM7 Kinase and Mitochondrial Dysfunction in Diabetic Heart Failure With Preserved Ejection Fraction: A Molecular Entry Point to a Complex Disease. [PDF]
Koitabashi N.
europepmc +1 more source
Abstract Aims Transthoracic echocardiography (TTE) is recommended as a key investigation in patients with acute heart failure (AHF) in major guidelines. However, utilization and benefits are yet to be known in Thai patients. The study aims to evaluate the benefits of TTE and identify factors associated with the decision to perform TTE on patients with ...
Koravich Lorlowhakarn+9 more
wiley +1 more source
Intravenous iron for iron deficiency in heart failure with preserved ejection fraction. A multivariate analysis. [PDF]
Viviane N+4 more
europepmc +1 more source